BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 36237546)

  • 1. Dual-tracer positron emission tomography/computed tomography as an imaging probe of
    Tsao CH; Jhou RH; Ke CC; Chang CW; Chang CW; Yang BH; Huang WS; Shih BF; Liu RS
    Front Med (Lausanne); 2022; 9():1008200. PubMed ID: 36237546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The importance of acetyl coenzyme A synthetase for 11C-acetate uptake and cell survival in hepatocellular carcinoma.
    Yun M; Bang SH; Kim JW; Park JY; Kim KS; Lee JD
    J Nucl Med; 2009 Aug; 50(8):1222-8. PubMed ID: 19617323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective evaluation of 18F-FDG and 11C-acetate PET/CT for detection of primary and metastatic hepatocellular carcinoma.
    Park JW; Kim JH; Kim SK; Kang KW; Park KW; Choi JI; Lee WJ; Kim CM; Nam BH
    J Nucl Med; 2008 Dec; 49(12):1912-21. PubMed ID: 18997056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [(11)C]acetate PET Imaging is not Always Associated with Increased Lipogenesis in Hepatocellular Carcinoma in Mice.
    Li L; Che L; Wang C; Blecha JE; Li X; VanBrocklin HF; Calvisi DF; Puchowicz M; Chen X; Seo Y
    Mol Imaging Biol; 2016 Jun; 18(3):360-7. PubMed ID: 26567114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic positron emission tomography imaging of cancer: Pairing lipid metabolism with glycolysis.
    Kwee SA; Lim J
    World J Radiol; 2016 Nov; 8(11):851-856. PubMed ID: 27928466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual-tracer PET/CT imaging in evaluation of metastatic hepatocellular carcinoma.
    Ho CL; Chen S; Yeung DW; Cheng TK
    J Nucl Med; 2007 Jun; 48(6):902-9. PubMed ID: 17504862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PET Imaging of Hepatocellular Carcinomas:
    Zhao J; Zhang Z; Nie D; Ma H; Yuan G; Su S; Liu S; Liu S; Tang G
    Mol Imaging; 2019; 18():1536012118821032. PubMed ID: 30799682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can positron emission tomography with the dual tracers [11 C]acetate and [18 F]fludeoxyglucose predict microvascular invasion in hepatocellular carcinoma?
    Cheung TT; Chan SC; Ho CL; Chok KS; Chan AC; Sharr WW; Ng KK; Poon RT; Lo CM; Fan ST
    Liver Transpl; 2011 Oct; 17(10):1218-25. PubMed ID: 21688383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia-induced modulation of glucose transporter expression impacts
    Xia H; Chen J; Gao H; Kong SN; Deivasigamani A; Shi M; Xie T; Hui KM
    Eur J Nucl Med Mol Imaging; 2020 Apr; 47(4):787-797. PubMed ID: 31832727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 11C-acetate and 18F-fluorodeoxyglucose positron emission tomography/computed tomography dual imaging for the prediction of response and prognosis after transarterial chemoembolization.
    Park S; Kim TS; Kang SH; Kim HB; Park JW; Kim SK
    Medicine (Baltimore); 2018 Sep; 97(37):e12311. PubMed ID: 30212970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 18F-Fluorodeoxyglucose uptake on positron emission tomography/computed tomography is associated with metastasis and epithelial-mesenchymal transition in hepatocellular carcinoma.
    Lee M; Jeon JY; Neugent ML; Kim JW; Yun M
    Clin Exp Metastasis; 2017 Apr; 34(3-4):251-260. PubMed ID: 28429188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. F-18 FDG in conjunction with 11C-choline PET/CT in the diagnosis of hepatocellular carcinoma.
    Wu HB; Wang QS; Li BY; Li HS; Zhou WL; Wang QY
    Clin Nucl Med; 2011 Dec; 36(12):1092-7. PubMed ID: 22064078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positron emission tomography/computed tomography with 18F-fluorocholine improve tumor staging and treatment allocation in patients with hepatocellular carcinoma.
    Chalaye J; Costentin CE; Luciani A; Amaddeo G; Ganne-Carrié N; Baranes L; Allaire M; Calderaro J; Azoulay D; Nahon P; Seror O; Mallat A; Soussan M; Duvoux C; Itti E; Nault JC
    J Hepatol; 2018 Aug; 69(2):336-344. PubMed ID: 29518452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A dual-tracer approach using [
    Veenstra EB; Ruiter SJS; de Haas RJ; de Jong KP; Erba PA; Dierckx RAJO; Noordzij W
    EJNMMI Res; 2023 Aug; 13(1):77. PubMed ID: 37644167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HRD1 attenuates the high uptake of [
    Li AM; Lin XW; Shen JT; Li M; Zheng QH; Zhou ZY; Shi M
    Nucl Med Biol; 2021; 96-97():27-34. PubMed ID: 33725499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 11C-acetate and 18F-FDG PET/CT for clinical staging and selection of patients with hepatocellular carcinoma for liver transplantation on the basis of Milan criteria: surgeon's perspective.
    Cheung TT; Ho CL; Lo CM; Chen S; Chan SC; Chok KS; Fung JY; Yan Chan AC; Sharr W; Yau T; Poon RT; Fan ST
    J Nucl Med; 2013 Feb; 54(2):192-200. PubMed ID: 23321459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioembolization with
    Ho CL; Chen S; Cheung SK; Leung YL; Cheng KC; Wong KN; Wong YH; Leung TWT
    Eur J Nucl Med Mol Imaging; 2018 Nov; 45(12):2110-2121. PubMed ID: 29948107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic value of combining ¹¹C-choline and ¹⁸F-FDG PET/CT in hepatocellular carcinoma.
    Castilla-Lièvre MA; Franco D; Gervais P; Kuhnast B; Agostini H; Marthey L; Désarnaud S; Helal BO
    Eur J Nucl Med Mol Imaging; 2016 May; 43(5):852-859. PubMed ID: 26577938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 11C-acetate PET imaging in hepatocellular carcinoma and other liver masses.
    Ho CL; Yu SC; Yeung DW
    J Nucl Med; 2003 Feb; 44(2):213-21. PubMed ID: 12571212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.